Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/17/2013 9:59:58 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Receives Favorable NASDAQ Listing Decision
5/16/2013 11:14:02 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces 20:1 Reverse Stock Split Effective After Market Close on May 10th
5/10/2013 11:26:16 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Reports Financial Results for the Third Quarter FY2013
3/19/2013 6:54:59 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces Third Quarter FY2013 Financial Results Conference Call and Webcast
3/14/2013 6:25:24 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Enters Into Definitive Agreements for Financing for Up to $2.1 Million in Gross Proceeds
2/22/2013 9:57:28 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Enters License and Supply Agreement for Dermacyte® Products With the Cosmetics Division of Valor SA
2/12/2013 10:09:26 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces it Will Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 11
1/31/2013 6:14:47 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces it Will Present at the 15th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference on February 11
1/30/2013 7:57:50 AM
More...
|
Oxygen Biotherapeutics, Inc. (OXBO) Announces it Will Present at OneMedForum Conference on Wednesday January 9th
1/9/2013 6:26:06 AM
More...
|
|